If you made any changes in Pure these will be visible here soon.

Personal profile


Dongbin completed his Bachelor of Science in Biology and Master of Science in Immunology, before doing his PhD and Postdoctoral research at the Garvan Institute in Sydney under the supervision of Prof Jonathan Sprent.

At Garvan, Dongbin used preclinical models to develop novel vaccine technologies that can massively expand tumour killing T cells. Dongbin is extending these exciting findings into more clinically relevant settings in the Translational Antigen Discovery Laboratory at Monash University.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Immunology, PhD, Stimulation of CD8 T cells with membrane vesicles prepared from antigen presenting cells, Garvan Institute of Medical Research (New South Wales)

19 Jul 201024 Jun 2015

Award Date: 31 Jul 2015

Research area keywords

  • cancer vaccine
  • preclincal development
  • dendritic cells
  • T cells
  • adjuvants
  • nanoparticles
  • immunotherapies
  • Immunopeptidomics

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or